ArticleCureus2021

Safety, Tolerability, and Immunogenicity of Prescribed Usage of Darbepoetin-Alfa (Hetero Biopharma) in Patients of Chronic Kidney Disease With Renal Anemia: A Post-Marketing Surveillance Study.

Shubhadeep D Sinha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.